Phage Therapy in Combating Multidrug-Resistant Gram-Negative Pathogens: A Scoping Review.

Sukri A, Lopes BS, Hanafiah A

Open source

DOI
10.3390/ph19050727
Published
2026 May 3
Container
Pharmaceuticals (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph19050727,
  title = {Phage Therapy in Combating Multidrug-Resistant Gram-Negative Pathogens: A Scoping Review.},
  author = {Sukri A and Lopes BS and Hanafiah A},
  year = {2026},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  doi = {10.3390/ph19050727},
  url = {https://doi.org/10.3390/ph19050727}
}

RIS

TY  - JOUR
TI  - Phage Therapy in Combating Multidrug-Resistant Gram-Negative Pathogens: A Scoping Review.
AU  - Sukri A
AU  - Lopes BS
AU  - Hanafiah A
PY  - 2026
JO  - Pharmaceuticals (Basel, Switzerland)
DO  - 10.3390/ph19050727
UR  - https://doi.org/10.3390/ph19050727
ER  - 

APA

A, S., BS, L., & A, H. (2026). Phage Therapy in Combating Multidrug-Resistant Gram-Negative Pathogens: A Scoping Review.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph19050727

Source records